Immunis
About:
Immunis a private biotechnology company developing a novel treatment for age and disease-related immune decline.
Website: https://immunisbiomedical.com
Top Investors: Healthspan Capital, Remiges Ventures, Continuum Health Ventures
Description:
Immunis a private biotechnology company developing a novel treatment for age and disease-related immune decline.
Total Funding Amount:
$30.4M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Irvine, California, United States
Founded Date:
2018-01-01
Contact Email:
contact(AT)immunisbiomedical.com
Founders:
Hans S. Keirstead
Number of Employees:
11-50
Last Funding Date:
2024-07-01
IPO Status:
Private
Industries:
© 2025 bioDAO.ai